4 天
Pharmaceutical Technology on MSNKeymed’s Stapokibart approved by NMPA for seasonal allergic rhinitisChina's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of Stapokibart to treat seasonal allergic rhinitis ...
Due to the risk of rebound congestion (known by some as rhinitis medicamentosa or nasal spray addiction), over-the-counter decongestant medication such as Afrin should not be used for more than three ...
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
Oxymetazoline nasal spray. National Library of Medicine: DailyMed. AFRIN ORIGINAL- oxymetazoline hydrochloride spray. Harvard Medical School, Harvard Health Publishing. Don't let decongestants squeeze ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
来自MSN25 天
What Is Allergic Rhinitis?Allergic rhinitis is the inflammation of nasal passageways ... with saline or a saltwater solution from a neti pot or nasal spray bottle. Doing this can help clear mucus from your nose.
A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...
PH284 nasal spray increased hunger in cancer cachexia patients, showing a 71% improvement in subjective hunger scores compared to baseline. The phase 2A study demonstrated PH284's safety, with no ...
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Introduction: Allergic rhinitis (AR) is a respiratory immune system disorder characterized by dysregulation ... notably characterized by a significant reduction in allergic inflammatory responses, ...
For patients with allergic rhinitis, twice-daily azelastine plus fluticasone cut nasal symptoms ... all treatments were administered as one spray twice daily to preserve blinding.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果